Country Specific Requirements Sample Clauses

Country Specific Requirements. The Equities Annex does not attempt to deal specifically with the position of UK equities. Participants who are contemplating using the equity repo annex for transactions in UK equities will, as with any transaction, need to check the position carefully in the specific context of any particular proposed transaction. Amongst the questions to be considered will be the detail of the stamp duty and stamp duty reserve tax position and also whether, in any particular case, the Buyer may be in a position to claim any amount from the UK authorities that could be within sub-paragraph (c)(ii), for example under the terms of an applicable tax treaty. 3.13
Sample 1Sample 2See All (4)
AutoNDA by SimpleDocs
Country Specific Requirements. The Parties will comply with the provisions of the CLIP.
Sample 1Sample 2Sample 3
Country Specific Requirements. If the Distribution Seller is located in Bangladesh, Colombia, Egypt, Guatemala, Kuwait, Netherlands, Pakistan, Russia, Thailand, the United Arab Emirates, or Uruguay, then the following provisions apply:
Sample 1Sample 2Sample 3
Country Specific Requirements. <insert additional provisions e.g. taxes, registration, etc. specific to the given country and attach any related documents as Exhibit 3, attached hereto. >
Sample 1
Country Specific Requirements. Pitney Xxxxx Inc. is a global corporation with subsidiary companies located around the world. This Privacy Addendum establishes our global principles (to the extent the law permits and/or requires) for the collection, use and disclosure of information gathered through our Sites. The country in which you are doing business with us or where the Site you are visiting is located or hosted may have specific requirements concerning Personal Information and may be found below. Australia Europe Latin America United States Australia Cross Border Data Transfer With respect to Personal Information received from Australia, your Personal Information may be disclosed to entities located in the U.S., U.K., or any other country necessary to fulfill the purposes outlined in this Privacy Addendum and we will adhere to applicable law and regulations regarding your Personal Information. As stated above, this includes the use of data transfer agreements and model contractual clauses, where available, between our corporate entities, our partners and our clients where required. Credit Information As described in Collecting Personal Information from Site Users, we may also collect your credit information to assess a credit application or to assist us to collect overdue payments. We may collect credit information from a business which provides information about commercial credit, a lender named in your credit application, any other applicant(s) or a credit reporting bureau which provides consumer credit reports, even if it is an application for commercial credit. When you apply for credit with us, you agree to us accessing your Personal Information (including credit-related information) held with a credit reporting bureau, even if there is a ban period in place, for the purposes of assessing an application for credit or in order to collect overdue payments. Credit reporting bureaus may use credit information they hold to respond to requests from us or other credit providers to "pre-screen" you for direct marketing. You can ask a CRB not to do this. However, if you are a borrower you may still receive direct marketing from us (unless you ask us not to) that has not been "pre-screened". Europe
Sample 1

Related to Country Specific Requirements

  • Quality Specifications SANMINA-SCI shall comply with the quality specifications set forth in its Quality Manual, incorporated by reference herein, a copy of which is available from SANMINA-SCI upon request.

  • Sublicense Requirements Any Sublicense:

  • Quality Requirements Performance Indicator Heading Indicator (specific) Threshold Method of Measurement Frequency of monitoring Consequence of Breach QUALITY Patient Safety - Incidents I1 Number of incidents Adverse incidents include the following: clinical or non clinical adverse events that have potential to cause avoidable harm to a patient, including medical errors or adverse events related to medical devices or other equipment. Clinical or non- clinical accidents, accidental injuries to staff and members of the public, verbal, physical or psychological abuse or harassment, unusual or dangerous occurrences, damage to trust property, plant or equipment, fire or flood, security, theft or loss, near misses are identified as any event where under different circumstances significant injury or loss may have occurred Number of recorded incidents in the contract month Monthly Remedial Action Plan brought to Performance Meeting following breach; action under Module C Clause 32 if needed I2 Number of Sis Definition of SUI according to trust policy and national guidance Number of Serious Untoward Incidents reported in contract month Monthly Remedial Action Plan brought to Performance Meeting following breach; action under Module C Clause 32 if needed S1 Percentage of eligible staff received child safeguarding training at level 2 (as identified in LSCB training strategy) 95% Number received training/ Number of identified staff requiring training Monthly S2 Percentage of eligible staff received adult safeguarding awareness training at level 2 ( as identified in K&M Safeguarding Vulnerable Adults training strategy) 95% Number of staff trained/ Number of identified staff requiring training Monthly

  • Technical Specifications The Technical Specifications furnished on the CD are intended to establish the standards for quality, performance and technical requirements for all labor, workmanship, material, methods and equipment necessary to complete the Work. When specifications and drawings are provided or referenced by the County, these are to be considered part of the Scope of Work, and to be specifically documented in the Detailed Scope of Work. For convenience, the County supplied specifications, if any, and the Technical Specifications furnished on the CD.

  • Technical Requirements 2.7.4.1 The NID shall provide an accessible point of interconnection and shall maintain a connection to ground.

  • Clinical Data and Regulatory Compliance The preclinical tests and clinical trials, and other studies (collectively, “studies”) that are described in, or the results of which are referred to in, Registration Statement, the Pricing Disclosure Package or the Prospectus were and, if still pending, are being conducted in all material respects in accordance with applicable laws, rules, regulations and policies of the Food and Drug Administration of the U.S. Department of Health and Human Services (the “FDA”) or any committee thereof or of any other U.S. or foreign government or drug or medical device regulatory agency, or health care facility Institutional Review Board; each description of the results of such studies is accurate and complete in all material respects and fairly presents the data derived from such studies, and the Company and its subsidiaries have no knowledge of any other studies the results of which are materially inconsistent with, or otherwise call into question, the results described or referred to in the Registration Statement, the Pricing Disclosure Package or the Prospectus; for such studies that have been or are being conducted, the Company and its subsidiaries have made all such filings and obtained all such approvals as may be required by foreign government or drug or medical device regulatory agencies, or foreign health care facility Institutional Review Boards; and no investigational new drug application filed by or on behalf of the Company or any of its subsidiaries with the FDA has been terminated or suspended by the FDA, and neither the FDA nor any applicable foreign regulatory agency has commenced, or, to the knowledge of the Company, threatened to initiate, any action to place a clinical hold order on, or otherwise terminate, delay or suspend, any proposed or ongoing studies conducted or proposed to be conducted by or on behalf of the Company or any of its subsidiaries.

  • Functional Requirements Applications must implement controls that protect against known vulnerabilities and threats, including Open Web Application Security Project (OWASP) Top 10 Risks and denial of service (DDOS) attacks.

  • Licensing Requirements The following licensing requirements shall apply when the applicable Florida Statute mandates specific licensing for Contractors engaged in the type of work covered by this solicitation.

  • Product Specifications The Company agrees that all Products sold to Xxxx hereunder shall conform to the respective specifications set forth on Schedule A or to such other specifications as are from time to time agreed upon by the Parties.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!